SPAGN Conference 2026: The power of the patient’s contribution to research

The session explored how patients can actively shape sarcoma research through patient-reported outcomes (PROs) and research biospecimens. Speakers highlighted the growing importance of capturing patients’ experiences, quality of life, and treatment impacts alongside traditional clinical outcomes, while emphasizing the need for more sarcoma-specific measurement tools. Discussions also focused on the critical role of tissue and blood samples in advancing research, the challenges of sample collection and consent, and the importance of patient engagement, collaboration, and data sharing to drive better treatments and outcomes for future sarcoma patients.

SPAGN Conference 2026: Unique Among Cancers: What Makes Sarcoma Different—and Why It Matters
▶︎

SPAGN Conference 2026: Unique Among Cancers: What Makes Sarcoma Different—and Why It Matters

SPAGN Conference 2026: Sarcoma treatment in motion: New therapies, trials, and approvals
▶︎

SPAGN Conference 2026: Sarcoma treatment in motion: New therapies, trials, and approvals

"Using Omics in Biomedical Research" & "Data Asset Management in the Era of Collaborative Science"
▶︎

"Using Omics in Biomedical Research" & "Data Asset Management in the Era of Collaborative Science"

Anthony Scaramucci on Trump, MAGA and the US Midterms  | The Mishal Husain Show
▶︎

Anthony Scaramucci on Trump, MAGA and the US Midterms | The Mishal Husain Show

Introduction to Genomic Biomarkers in Radiation Oncology
▶︎

Introduction to Genomic Biomarkers in Radiation Oncology

SPAGN Conference 2026: In the doctor’s shoes: Case discussions
▶︎

SPAGN Conference 2026: In the doctor’s shoes: Case discussions

Empowering Allied Health Professionals Through Education in Organ, Tissue and Cell Donation and...
▶︎

Empowering Allied Health Professionals Through Education in Organ, Tissue and Cell Donation and...

What You Need To Know About The Parathyroid Glands with Dr. Deva Boone
▶︎

What You Need To Know About The Parathyroid Glands with Dr. Deva Boone

Antineoplastic Agents | Clinical Medicine
▶︎

Antineoplastic Agents | Clinical Medicine

Future of Integrated Health – Interactive Roundtable
▶︎

Future of Integrated Health – Interactive Roundtable

SPAGN Conference 2026: Collaborating for Impact: Building effective research partnerships
▶︎

SPAGN Conference 2026: Collaborating for Impact: Building effective research partnerships

The Waiting Game: Waldenström Macroglobulinemia and Mental Health
▶︎

The Waiting Game: Waldenström Macroglobulinemia and Mental Health

National PGx Genomic Network of Excellence meeting - London - March 2026
▶︎

National PGx Genomic Network of Excellence meeting - London - March 2026

Primary Hyperparathyroidism - Investigation and management
▶︎

Primary Hyperparathyroidism - Investigation and management

Rethinking the future of MS care – Event 28 April 2026 Professor Hanneke Hulst
▶︎

Rethinking the future of MS care – Event 28 April 2026 Professor Hanneke Hulst

Boston Public Radio, The Curiosity Desk, & The Culture Show Live Monday, June 15, 2026
▶︎

Boston Public Radio, The Curiosity Desk, & The Culture Show Live Monday, June 15, 2026

Focused Ultrasound: Origins, Challenges, and Clinical Promise (Webinar)
▶︎

Focused Ultrasound: Origins, Challenges, and Clinical Promise (Webinar)

Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals
▶︎

Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals

SPAGN Conference 2026: From sequencing to personalized therapy
▶︎

SPAGN Conference 2026: From sequencing to personalized therapy

Multiple Myeloma in 2025 and Treatment Options
▶︎

Multiple Myeloma in 2025 and Treatment Options